ARDS

News
Bayer

Bayer pulls plug on respiratory drug PEG-ADM

Bayer revealed in its second-quarter results update this morning that it has stopped the development of adrenomedullin pegol (PEG-ADM), which had reached phase 2 for the t

Events
ARDS Pharmaphorum Banners
Partner Content

2nd ARDS Drug Development Summit

Acute Respiratory Distress Syndrome (ARDS) is a growing and concerning unmet medical need with no effective therapeutic, and a serious medical burden in a world with or without COVID-19.